Aprea Therapeutics, Inc. (APRE)
R&D Expenses
$6.72M
TTM · Period ending: · USD
APRE R&D Expenses
Latest reported$6.72Mperiod ending
Latest reported$6.72Mperiod ending
APRE TTM R&D Expenses ($20.95M → $6.72M)
TTM R&D Expenses
High-resolution chart · PNG
APRE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 6,720,965 | |
| 6,171,136 | |
| 7,043,035 | |
| 8,393,282 | |
| 9,600,764 | |
| 10,246,230 | |
| 9,363,537 | |
| 9,050,139 | |
| 8,326,343 | |
| 7,971,321 | |
| 7,627,490 | |
| 6,113,208 | |
| 5,108,181 | |
| 85,737,317 | |
| 88,570,352 | |
| 92,501,100 | |
| 97,399,140 | |
| 21,221,604 | |
| 23,895,875 | |
| 28,761,800 | |
| 31,507,279 | |
| 35,547,051 | |
| 37,879,325 | |
| 36,593,239 | |
| 32,742,553 | |
| 26,368,350 | |
| 20,950,672 | |
| 17,303,600 | |
| 14,700,213 |